Fluotracer

Fluotracer (Fludeoxyglucose (18F)) is a radiopharmaceutical used for diagnostic imaging. This intravenous medication aids in detecting metabolic activity, commonly employed in PET scans.

Fluotracer is primarily used in positron emission tomography (PET) scans to visualize metabolic processes. It helps identify areas of high glucose metabolism, which can be indicative of various conditions. The medication is often utilized in oncological, neurological, and cardiovascular assessments.

Fluotracer works by accumulating in tissues with high metabolic activity, making them visible on PET scans. This can help healthcare professionals observe areas of interest within the body. The effects are temporary and specifically related to the imaging process.

Fluotracer should be handled with care due to its radioactive nature. It is essential to follow proper safety protocols to minimize exposure. Pregnant women and individuals with certain medical conditions should consult their healthcare provider before use.

Fluotracer may interact with other medications or substances that affect glucose metabolism. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain foods might also influence the accuracy of the imaging results.